drug · antibody
patient view →romosozumab
Phase 3updated 2mo agoby $AMGN AMGEN INC🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 2 investigational indications.
targets
Sclerostin
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that